Affordable Access

Clinical impact of synchronous and metachronous malignancies in patients with oral cancer.

Authors
Type
Published Article
Journal
International journal of oral and maxillofacial surgery
Publication Date
Volume
22
Issue
5
Pages
282–284
Identifiers
PMID: 8245567
Source
Medline
License
Unknown

Abstract

In a retrospective study, 20 of 379 patients (5.2%) with cancer of the oral cavity developed second malignant tumors (SMT) at various sites. The diagnosis of SMT was made with an average delay of 49.2 months. In view of the increasing incidence of SMT after curative treatment of oral cancer, the use of chemopreventive drugs should be considered.

Statistics

Seen <100 times